Clinical Trials Browser

Interventional × sitravatinib × 30 days × Clear all

NCT04164199 2026-06-03

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

Phase 3 Completed

Advanced Malignancies

NCT05542342 2026-06-01

SITISVEAL

Phase 2 Completed

16 enrolled 14 charts

Melanoma